231 related articles for article (PubMed ID: 35887246)
1. Development of a Multi-Epitope Vaccine for
Li G; Shu J; Jin J; Shu J; Feng H; Chen J; He Y
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887246
[No Abstract] [Full Text] [Related]
2. A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
Gao Z; Chen L; Song T; Pan X; Li X; Lu G; Tang Y; Wu X; Zhao B; Zhang R
Vaccine; 2022 Apr; 40(16):2370-2378. PubMed ID: 35307227
[TBL] [Abstract][Full Text] [Related]
3. Oral Immunization with Attenuated
Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
[TBL] [Abstract][Full Text] [Related]
4. Genomic Variability and Post-translational Protein Processing Enhance the Immune Evasion of
Li G; Obeng E; Shu J; Shu J; Chen J; Wu Y; He Y
Front Immunol; 2020; 11():510943. PubMed ID: 33117335
[No Abstract] [Full Text] [Related]
5. Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.
Tao Y; Yang R; Shu J; Zheng W; Chen J; Wu Y; He Y
BMC Vet Res; 2020 Sep; 16(1):342. PubMed ID: 32938456
[TBL] [Abstract][Full Text] [Related]
6. Systems Immunology Characterization of Novel Vaccine Formulations for
Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
Front Immunol; 2019; 10():1087. PubMed ID: 31178860
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration.
Hao F; Bai Y; Xie X; Yuan T; Wei Y; Xiong Q; Gan Y; Zhang L; Zhang Z; Shao G; Feng Z
Vaccine; 2022 Oct; 40(42):6074-6083. PubMed ID: 36109278
[TBL] [Abstract][Full Text] [Related]
8. A concise review of vaccines against Mycoplasma hyopneumoniae.
Tao Y; Shu J; Chen J; Wu Y; He Y
Res Vet Sci; 2019 Apr; 123():144-152. PubMed ID: 30665029
[TBL] [Abstract][Full Text] [Related]
9. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
10. Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice.
Galli V; Simionatto S; Marchioro SB; Klabunde GH; Conceição FR; Dellagostin OA
Clin Vaccine Immunol; 2013 Sep; 20(9):1370-6. PubMed ID: 23803903
[TBL] [Abstract][Full Text] [Related]
11. Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets.
Bandrick M; Theis K; Molitor TW
BMC Vet Res; 2014 Jun; 10():124. PubMed ID: 24903770
[TBL] [Abstract][Full Text] [Related]
12. Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and
Tao Y; Li G; Zheng W; Shu J; Chen J; Yang F; Wu Y; He Y
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505747
[No Abstract] [Full Text] [Related]
13. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
14. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component.
Walders B; Raschke A; Neugebauer M; Geuther E; Bertling W; Reiser C; Buck A; Strich S; Hess J
Res Vet Sci; 2005 Apr; 78(2):135-41. PubMed ID: 15563920
[TBL] [Abstract][Full Text] [Related]
15. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
16. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
[TBL] [Abstract][Full Text] [Related]
17. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
Bourry O; Fablet C; Simon G; Marois-Créhan C
Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.
Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J
Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417
[TBL] [Abstract][Full Text] [Related]
20. [Development of an ELISA for identification of immunodominant protein antigens of Mycoplasma hyopneumoniae].
Zhou Y; You F; Zhong J; Wang H; Ding H
Sheng Wu Gong Cheng Xue Bao; 2018 Jan; 34(1):44-53. PubMed ID: 29380570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
